T. Rowe Price reports 5.5% stake in StoneX
T. Rowe Price Associates, Inc. filed a Schedule 13G reporting beneficial ownership of 2,851,483 shares of StoneX Group Inc. common stock, representing 5.5% of the class as of 12/31/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
T. Rowe Price Associates, Inc. filed a Schedule 13G reporting beneficial ownership of 2,851,483 shares of StoneX Group Inc. common stock, representing 5.5% of the class as of 12/31/2025. T. Rowe Price reports sole voting power over 2,812,135 shares and sole dispositive power over 2,851,468 shares, with no shared voting or dispositive power.
The firm states the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of StoneX Group. The filing also notes that T. Rowe Price Associates expressly denies being the beneficial owner of the securities referred to, despite reporting them for Schedule 13G purposes.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does T. Rowe Price Associates’ Schedule 13G filing for SNEX report?
How large is T. Rowe Price Associates’ ownership stake in StoneX Group (SNEX)?
Is T. Rowe Price Associates’ SNEX position intended to influence control of the company?
What type of reporting person is T. Rowe Price in this SNEX Schedule 13G?
On what date was T. Rowe Price’s SNEX ownership measured for this Schedule 13G?
AI-generated analysis. How Rhea-AI works. Not financial advice.